Literature DB >> 31326045

Methodological Quality Assessment of Meta-analyses and Systematic Reviews of the Relationship Between Periodontal and Systemic Diseases.

Zuhair S Natto1, Alhassan Hameedaldain2.   

Abstract

OBJECTIVES: The aims of this article are to identify all the published systematic reviews (SRs) and meta-analyses (MAs) that studied the relationship between periodontal and systemic diseases and to assess their quality using 2 scales (the Overview Quality Assessment Questionnaire [OQAQ] and A Measurement Tool to Assess Systematic Reviews [AMSTAR] checklist).
METHODS: For SRs and MAs to be included, they should have investigated one of the following systemic diseases: pulmonary conditions, cardiac conditions, endocrine conditions, cancer, blood disorders, psychological conditions, anxiety, depression, mood disorders, and several other diseases. Two investigators screened MEDLINE via PubMed, Embase, Scopus, Web of Science, and the Cochrane Database of Systematic Reviews. The tools used to evaluate quality were the AMSTAR scale and OQAQ. The protocol was prospectively registered in PROSPERO (CRD42018102208).
RESULTS: The search strategy found 691 unique articles, 42 of which met the eligibility criteria and were included in this review. Diabetes mellitus was the most investigated disease (14 out of 42 studies), followed by obesity (11 studies) and cardiovascular diseases (5 studies). A total of 40 reviews reported on the characteristics of included studies, and, as per the AMSTAR scale, 39 reviews had an a priori design. The number of reviews that fulfilled the status of publication criterion was the lowest (7 reviews only), followed by the number used in the assessment of publication bias (11 reviews). The number of high-quality reviews was higher with the OQAQ than with the AMSTAR checklist (33 vs 25 studies), but the AMSTAR showed a higher number of medium-quality reviews than the OQAQ (14 vs 6 studies). Both showed the same number of low-quality reviews.
CONCLUSIONS: High-quality SRs and MAs are crucial to understanding the relationship between systemic and periodontal diseases. Medical practitioners must be able to inform patients about oral health and specific periodontal health concerns.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Level of evidence; Periodontal disease; Quality of publications; Systemic disease

Mesh:

Year:  2019        PMID: 31326045     DOI: 10.1016/j.jebdp.2018.12.003

Source DB:  PubMed          Journal:  J Evid Based Dent Pract        ISSN: 1532-3382            Impact factor:   5.267


  6 in total

1.  The Effect Of Social Media On The Choice Of Dental Patients: A Cross-Sectional Study In The City Of Jeddah, Saudi Arabia.

Authors:  Abdullah Alalawi; Hamad Aljuaid; Zuhair S Natto
Journal:  Patient Prefer Adherence       Date:  2019-10-03       Impact factor: 2.711

2.  Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study.

Authors:  Mohammad Helmi; Sara AlOsaimy; J Max Goodson; Hatice Hasturk; Zuhair S Natto
Journal:  BMC Oral Health       Date:  2019-11-27       Impact factor: 2.757

3.  First Molars-Incisors Rate and Pattern of Bone Loss: A Cross-Sectional Analysis of CBCT Images.

Authors:  Faraedon Mostafa Zardawi
Journal:  Diagnostics (Basel)       Date:  2022-06-24

4.  Psychological resilience during COVID-19: a meta-review protocol.

Authors:  Katie Seaborn; Mark Chignell; Jacek Gwizdka
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692

5.  Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Zuhair S Natto; Wael Yaghmoor; Heba K Alshaeri; Thomas E Van Dyke
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

6.  Prevalence of periodontitis and alveolar bone loss in a patient population at Harvard School of Dental Medicine.

Authors:  Mohammad F Helmi; Hui Huang; J Max Goodson; Hatice Hasturk; Mary Tavares; Zuhair S Natto
Journal:  BMC Oral Health       Date:  2019-11-21       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.